BridgeBio Pharma

2 open remote positions

BridgeBio Pharma pioneers a "moneyball for biotech" model, pooling early-stage research to reduce risk and develop life-changing medicines for rare diseases. As a biotech company with a focus on innovation, they value curiosity and experimentation in a collaborative, empowered culture.

Salary Distribution 2 of 2 jobs

PTO Distribution 2 of 2 jobs

Unlimited PTO 2 jobs (100%)

Benefits Overview 2 of 2 jobs

401(k) (2) Dental (2) Medical (2) PTO (2) Parental Leave (2) Vision (2) ESPP (1) Mental Health (1)

Open Positions

$175,900–$222,000/yr
US Unlimited PTO

  • Lead KOL strategy and relationship development across endocrinology and rare disease communities for the encaleret launch.
  • Drive congress and society engagement to advance disease education and generate field insights.
  • Collaborate cross-functionally to align KOL engagement with commercial, medical, and access strategies.

US Unlimited PTO

  • Drive the launch of Infigratinib, a first-in-class therapy for achondroplasia, by developing and executing a dynamic territory business plan targeting geneticists, pediatric endocrinologists, and skeletal dysplasia specialists.
  • Build and maintain relationships with key opinion leaders (KOLs) and multidisciplinary clinic teams, leveraging deep clinical expertise and sales data to identify growth opportunities.
  • Operate with an 'One Bridge' mindset, collaborating cross-functionally with Field Medical Directors, Reimbursement Managers, and the HUB to ensure customer and family satisfaction.